Patients with GCA receiving combination IVMP/MTX with lower-dose prednisone had lower cumulative GC doses and fewer related side effects vs SOC.
NCCN updated its SCLC guidelines to recommend testing in patients with suspected PNS; however, researchers found uptake in the US is low.